Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

10 results
Display

Clinical Application of F-18 FDG PET/PET-CT in gastrointestinal tumors

Choi YY

  • KMID: 1893641
  • Hanyang Med Rev.
  • 2007 Nov;27(4):28-36.
Positron emission tomography (PET) is a functional imaging modality which has been documented to be useful in clinical oncology. Oncologic PET imaging has been used for a wide variety of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Application of PET in Head and Neck Cancer

Kim JS, Lee JH

  • KMID: 1893639
  • Hanyang Med Rev.
  • 2007 Nov;27(4):16-22.
Head and neck cancers are the sixth most common type of human cancer worldwide. Squamous cell carcinomas are the most common cancer of the head and neck. Due to the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Clinical Role of FDG PET in Malignant Lymphoma

Cheon GJ

  • KMID: 1893646
  • Hanyang Med Rev.
  • 2007 Nov;27(4):66-75.
FDG PET is a functional and metabolic imaging modality to detect lesions with altered glycolytic activity. Conventional imaging modalities, such as CT or MRI, provide tissue information based on anatomical...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
PET Imaging for Gynecologic Malignancy

Won KS

  • KMID: 1893645
  • Hanyang Med Rev.
  • 2007 Nov;27(4):59-65.
The utility of positron emission tomography (PET) in gynecologic malignancy has increased rapidly in recent years. This review examines publications in this area. PET scans in gynecologic malignancy are mostly...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Role of fluorodeoxyglucose PET in the management of breast cancer

Lee WH, Yoo IR

  • KMID: 1893643
  • Hanyang Med Rev.
  • 2007 Nov;27(4):43-51.
In breast cancer, FDG PET is more accurate than conventional imaging methods for detecting distant metastases or local recurrences, and enables early ssessment of treatment response in patients undergoing primary...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
New Trend of tumor PET imaging radiopharmaceuticals

Oh SJ

  • KMID: 1893638
  • Hanyang Med Rev.
  • 2007 Nov;27(4):4-15.
Tumor PET imaging with radiopharmaceuticals plays a major role in the understanding of tumor biological information and for diagnosis of tumorswith non-invasive methods. These radiopharmaceuticals can be divided into two...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Role of Positron Emission Tomography(PET) in Radiation Treatment Planning

Hwang HS, Bae HS

  • KMID: 1893647
  • Hanyang Med Rev.
  • 2007 Nov;27(4):76-85.
Molecular imaging, in particular, positron emission tomography(PET) has brought an additional dimension to management for patients with cancer. It may lead to a change in staging and treatment management. In...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Use of PET in Esophageal Cancer

Choi JY

  • KMID: 1893640
  • Hanyang Med Rev.
  • 2007 Nov;27(4):23-27.
Esophageal cancer is one of the gastrointestinal malignancies that have an unfavorable prognosis. Whole body positron emission tomography (PET) using F-18 Fluorodeoxyglucose (FDG) has been used for characterizing focal lesions,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
PET oncology; Lung cancer

Lee WW

  • KMID: 1893642
  • Hanyang Med Rev.
  • 2007 Nov;27(4):37-42.
Lung cancer constitutes non-small cell lung cancer and small cell lung cancer. Positron emission tomography (PET) using F-18 labelled fluoro-deoxy glucose (FDG) has been evolving from a promising diagnostic tool...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The role of Positron Emission Tomography in hepatobiliary cancers

Yun M

  • KMID: 1893644
  • Hanyang Med Rev.
  • 2007 Nov;27(4):52-58.
Imaging approach for early diagnosis, accurate staging, and the evaluation of treatment response has been consisted of anatomical and functional imaging methods. The anatomical image usually depends on high spatial...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr